COMPARISON OF PARATHYROIDECTOMIES WITH PARICALCITOL OR CINACALCET FOR TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS PATIENTS

被引：0
|
作者：
Walton, Surrey M. [1 ]
Schumock, Glen T. [1 ]
Lee, Todd A. [1 ]
Marx, Steven E. [2 ]
Audhya, Paul [2 ]
Andress, Dennis L. [2 ]
机构：
[1] Univ Illinois, Chicago, IL USA
[2] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2009年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
222
引用
收藏
页码：A78 / A78
页数：1
相关论文
共 50 条
  • [31] Long-term outcomes of cinacalcet and paricalcitol titration protocol for treatment of secondary hyperparathyroidism
    Lazar, Eric
    Hebert, Katrina
    Poma, Tammy
    Stankus, Nicole
    AMERICAN JOURNAL OF NEPHROLOGY, 2007, 27 (03) : 274 - 278
  • [32] CINACALCET VS. PARICALCITOL IN HEMODIALYSIS PATIENTS
    Kaperonis, Nickos
    Kourvelou, Christine
    Sgantzos, Aris
    Nastou, Dimitra
    Ntatsis, George
    Ziakka, Stavroula
    Karakasis, Filippos
    Nikolopoulos, Vasileios
    Zoubaniotou, Dimitra
    Koutsovasili, Alexandra
    Zagorianakos, Antonis
    Kolovos, Vasileios
    Papagalanis, Nikos
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 497 - 498
  • [33] Decreases in Parathyroid Gland Volume after Cinacalcet Treatment in Hemodialysis Patients with Secondary Hyperparathyroidism
    Ichii, Mitsuru
    Ishimura, Eiji
    Okuno, Senji
    Chou, Hidenori
    Kato, Yoko
    Tsuboniwa, Naoki
    Nagasue, Kyoko
    Maekawa, Kiyoshi
    Yamakawa, Tomoyuki
    Inaba, Masaaki
    Nishizawa, Yoshiki
    NEPHRON CLINICAL PRACTICE, 2010, 115 (03): : C195 - C202
  • [34] Cinacalcet HCL for Treatment of Secondary Hyperparathyroidism (SHPT) in Hemodialysis Patients: A Single Centre Experience
    Qaisar, Mansoor Abbas
    Nadeem, Muhammad
    Chattah, Fateh Sher
    Roop, Zarmina
    Hashir, Muhammad Mujtaba
    Iqbal, Bushra
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (04): : 995 - 997
  • [35] Cinacalcet treatment significantly deceases parathyroid gland volume in hemodialysis patients with secondary hyperparathyroidism
    Ishimura, Eiji
    Ichii, Mitsuru
    Okuno, Senji
    Inaba, Masaaki
    Nishizawa, Yoshiki
    ENDOCRINE JOURNAL, 2010, 57 : S491 - S491
  • [36] Long-term therapy with paricalcitol for secondary hyperparathyroidism in hemodialysis patients
    Pai, AB
    Lin, S
    Arruda, JAL
    Lau, AH
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2003, 26 (06): : 484 - 490
  • [37] Long-term therapy with paricalcitol for secondary hyperparathyroidism in hemodialysis patients
    Lau, A.H. (alanlau@uic.edu), 1600, Wichtig Editore s.r.l. (26):
  • [38] Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients - Reply
    Coyne, DW
    Sprague, SM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (06) : 1083 - 1084
  • [39] Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients
    Seeherunvong, Wacharee
    Nwobi, Obioma
    Abitbol, Carolyn L.
    Chandar, Jayanthi
    Strauss, Jose
    Zilleruelo, Gaston
    PEDIATRIC NEPHROLOGY, 2006, 21 (10) : 1434 - 1439
  • [40] No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial
    Hansen, Ditte
    Rasmussen, Knud
    Danielsen, Henning
    Meyer-Hofmann, Helmut
    Bacevicius, Egidijus
    Lauridsen, Thomas G.
    Madsen, Jens K.
    Tougaard, Birgitte G.
    Marckmann, Peter
    Thye-Roenn, Peter
    Nielsen, Jorgen E.
    Kreiner, Svend
    Brandi, Lisbet
    KIDNEY INTERNATIONAL, 2011, 80 (08) : 841 - 850
12345